Combined effects of bacteriophage vB_SauM-515A1 and antibiotics on the Staphylococcus aureus clinical isolates

Комбинированное действие бактериофага vB_SauM-515A1 и антибиотиков на клинические изоляты Staphylococcus aureus
Maria A. Kornienko, Egor A. Shitikov, Н. К. Абдраймова, Dmitry Bespiatykh, NS Kuptsov, Roman B. Gorodnichev
2022-10-01

Staphylococcus aureusantibiotic–phage combination therapylytic bacteriophage vB_SauM-515A1multidrug-resistant clinical isolatesmultiplicity of infection
Currently, the search for new therapy options for infectious diseases caused by multidrug-resistant Staphylococcus aureus is a priority. Combining antibiotics with virulent (lytic) bacteriophages may be considered a viable alternative to conventional antibiotic therapy. The study was aimed to assess the combined effects of the lytic bacteriophage vB_SauM-515A1 of Herelleviridae family and antibiotics of various classes on the Staphylococcus aureus clinical strains. Strains (n = 4) belong to the clinically significant sequence types ST1, ST8, ST121 and are characterized by multidrug resistance. Efficiency of the combination use of two antibacterial agents was assessed by comparison of optical densities of the test samples and controls after 24 hrs. of incubation. Mutually enhancing activities of bacteriophage used in combination with oxacillin, tetracycline and linezolid were revealed, in contrast to the separate use of each agent. Efficiency generally increased with the selected optimum multiplicity of infection values. No antagonism was revealed when combining the phage with antibiotics. Thus, virulent bacteriophage vB_SauM515A1 can be considered as a possible auxiliary therapeutic agent for antimicrobial-resistant strains of Staphylococcus aureus.
1
Combination efficacy generally increased at selected optimal multiplicity-of-infection values.
2
No antagonistic interactions were observed, supporting vB_SauM-515A1 as a potential adjunctive therapy for antimicrobial-resistant S. aureus.
3
Phage combinations with oxacillin, tetracycline, and linezolid showed mutually enhanced antibacterial activity compared with either agent alone.
4
The strains represented clinically significant sequence types ST1, ST8, and ST121.
5
The study evaluated lytic bacteriophage vB_SauM-515A1 combined with antibiotics against four multidrug-resistant S. aureus clinical strains.

Multidrug-resistant clinical Staphylococcus aureus strains treated with lytic bacteriophage vB_SauM-515A1 and antibiotics

The combined antibacterial efficacy and interaction of lytic bacteriophage vB_SauM-515A1 with oxacillin, tetracycline, linezolid, and other antibiotics

Publication Details
Publication Date
2022-10-01
Journal
Publisher
ISSN
Cited by
5
Access Type
Author Information
Authors
Maria A. Kornienko
Egor A. Shitikov
Н. К. Абдраймова
Dmitry Bespiatykh
NS Kuptsov
Roman B. Gorodnichev
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%